A secret that hides Recursion Pharmaceuticals Inc’s strength (NASDAQ:RXRX)
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, up 3.96% to $8.92. RXRX stock price is now -18.07% away from the 50-day moving average and -4.37% away from the 200-day moving average. The market capitalization of the company currently stands at $1.93B. With the price target of $8, Morgan Stanley […]
Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $8.77, down -6.40% from the previous session. RXRX stock price is now -20.88% away from the 50-day moving average and -5.91% away from the 200-day moving average. The market capitalization of the company currently stands at $1.89B. With the price target of $8, […]
A breakdown of the latest mutual funds holding Recursion Pharmaceuticals Inc (RXRX)
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, down -1.45% to $10.17. RXRX stock price is now -8.49% away from the 50-day moving average and 9.14% away from the 200-day moving average. The market capitalization of the company currently stands at $2.19B. With the price target of $8, Morgan Stanley […]
How should investors evaluate Recursion Pharmaceuticals Inc (NASDAQ:RXRX)?
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, down -5.87% to $10.75. RXRX stock price is now -4.81% away from the 50-day moving average and 16.08% away from the 200-day moving average. The market capitalization of the company currently stands at $2.32B. With the price target of $8, Morgan Stanley […]
Do investors have a safe investment in Recursion Pharmaceuticals Inc (NASDAQ:RXRX)?
The price of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares last traded on Wall Street rose 14.41% to $9.53. RXRX stock price is now 46.90% away from the 50-day moving average and 21.34% away from the 200-day moving average. The market capitalization of the company currently stands at $2.06B. With the price target of $8, Morgan Stanley […]
Recursion Pharmaceuticals Inc (RXRX) Price Aside, RXRX Fundamentals Booming Beyond Compare
The price of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares last traded on Wall Street rose 4.51% to $7.42. Based on available information, 6 analysts follow Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and a low of […]
Stocks of Recursion Pharmaceuticals Inc [RXRX] are gaining investors’ attention: here’s why
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $7.02, up 7.50% from the previous session. As of this writing, 7 analysts cover Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and a […]
Does Recursion Pharmaceuticals Inc (NASDAQ:RXRX) presents a BIG investment opportunity?
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, up 3.67% to $6.78. According to the data, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) has 7 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and […]
Does Recursion Pharmaceuticals Inc (NASDAQ:RXRX) warrant a purchase right now? What to Consider Before Making a Decision
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded 11.15% higher at $7.18 on Wall Street last session. In accordance with the data, 7 analysts cover Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and a low of $9.00, […]
Reasons why Recursion Pharmaceuticals Inc’s (NASDAQ:RXRX) fundamentals are futile
The price of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares last traded on Wall Street fell -7.86% to $5.63. RXRX stock price is now -21.54% away from the 50-day moving average and -29.91% away from the 200-day moving average. The market capitalization of the company currently stands at $1.19B. With the price target of $8, Morgan Stanley […]
